Brexa Advan Launches Comprehensive Support Services for Life Sciences in 2026

Brexa Advan's New Initiative in Life Sciences

In a pivotal move set to reshape the life sciences industry, Brexa Advan has announced the launch of a comprehensive one-stop technical service aimed at supporting pharmaceutical development processes, including clinical research and regulatory submissions. This initiative follows the absorption of RPM, effective July 1, 2026, enhancing the support structure across various fields: pharmaceuticals, chemicals, food, cosmetics, environment, and energy.

The Rationale Behind the Integration

The life sciences sector is undergoing a significant transformation. The emergence of diverse modalities in drug discovery, such as low-molecule pharmaceuticals, antibody therapies, RNA therapies, gene and cell therapies, and regenerative medicine, necessitates a more specialized and sophisticated development process. Concurrently, the food, chemical, cosmetics, environment, and energy sectors are witnessing a surge in demand for research and development talent, driven by sustainability, the utilization of artificial intelligence, and advancements in biotechnology.

However, many companies face several challenges, including:

- Difficulty in hiring specialized personnel
- Lack of immediate talents
- Increased burden in nurturing young professionals
- Coordination difficulties with various contractors during different phases of development
- Career limitations for researchers due to structural issues

We believe these issues stem not from a shortage of talent, but from a lack of frameworks that nurture and support specialized personnel. This integration is a bold step towards addressing these challenges.

Achievements Throughout the Years

Each company has bolstered its strengths in different areas:
BREXA Advan, founded 28 years ago, has made its mark in recruitment and talent services for research sectors, excelling in:

- Talent acquisition
- Education
- Research support
- Career development

Each year, BREXA Advan successfully transitions over 150 researchers into manufacturing roles, acquiring tremendous expertise in the recruitment and education of science graduates.

On the other hand, RPM has established its reputation in pharmaceutical development, specializing in CRO business and technical staffing for pharmaceutical professionals. Their experience extends to:

- Clinical development
- Regulatory submissions
- Pharmacovigilance
- Quality assurance
- Medical writing

With around 500 development engineers, RPM boasts an impressive array of support experiences.

Both entities share a common commitment to maximizing the value of specialized personnel.

Value Realized Through Integration

The integration now allows for uninterrupted support from research and development through to post-marketing.

Areas of Focus:

- Drug discovery research
- Basic research
- Non-clinical tests
- Clinical development
- CMC and manufacturing process development
- Regulatory submissions
- Quality assurance and management
- Pharmacovigilance
- Medical affairs
- Post-marketing surveys
- Supply chain and logistics

Companies can now avoid engaging multiple partners for different phases of development, thereby fostering flexible technical support that encompasses entire projects.

Case Studies:

1. Transition from Research to Clinical Development: A young engineer working in analytical research at a chemical company underwent training in pharmaceutical development. After joining a clinical development project as a CRA, they participated in several international collaborative trials, eventually transitioning to a pharmaceutical company and expanding their career in drug development.

2. Career Change to Quality Assurance: An employee from the quality department of a food manufacturing company participated in GMP and GQP training. After joining a pharmaceutical company’s quality assurance department, they engaged in audits and quality system development, now serving as a quality assurance leader.

3. Combining Technical Staffing and CRO Services: A pharmaceutical company required rapid structure for CRA, regulatory submissions, PV, and medical writing for a new project launch. We combined technical staffing with CRO services, successfully advancing the project without schedule delays.